+1 877 705 1914• 24 / 7
HIPAA Compliant
ISO 27001 Certified

Actively Recruiting

Phase 2
Age: 18Years +
All Genders
ID07210112

Study of Psilocybin Combined with Trazodone for Treatment-resistant Depression A Randomized Controlled Proof-of-Concept Trial

Led by Centre Hospitalier St Anne · Updated on 2026-09-21

112

Participants Needed

1

Research Sites

25 weeks

Total Duration

AI-Summary

What This Trial Is About

This research evaluates the combination of psilocybin and trazodone for adults with treatment-resistant depression TRD, a condition marked by depressive episodes not responding to at least two antidepressant treatments. The study aims to understand how blocking the 5-HT2A receptor with trazodone affects the therapeutic benefits and subjective effects of psilocybin. Researchers hypothesize that psilocybins benefits may partially occur independently of this receptors activation. Participants are randomly assigned to one of four groups psilocybin with a placebo for trazodone, psilocybin with a low dose of trazodone 5 mg, psilocybin with a higher dose of trazodone 30 mg, or placebo psilocybin with 30 mg trazodone. Psilocybin and trazodone or their placebos are given orally once under medical and psychological supervision. The study is double-blind and placebo-controlled, involving 112 adults. During the study, participants undergo assessments of depression symptoms using scales like the Montgomery-sberg Depression Rating Scale MADRS over several time points, including baseline and up to three months after treatment. Other evaluations include suicidal risk, mood, quality of life, and drug subjective effects. Safety is monitored through adverse event tracking and laboratory tests. The primary outcome is the change in depression severity one month after treatment.

CONDITIONS

Brief Title

Efficacy of Psilocybin and Trazodone Combination in Treatment-resistant Depression: a Randomized Controlled Proof-of-concept Study (PSILOTRAZ)

Research Team

L

Lucie BERKOVITCH, MD

Not the Right Trial for You?

Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.

Already have an account? Log in here